Content Status
Type
Linked Node
Second Line anti TB drugs
Learning ObjectivesSecond Line anti TB drugs
H5Content
Content
The anti-TB drugs recommended for treatment of Multi- and Extensively Drug-resistant (M/XDR) TB patients are grouped into three groups – A, B and C (Figure below).
Figure: Groups A, B and C of Anti-TB Drugs used in Treatment of M/XDR-TB Patients
Grouping of drugs is done based on their efficacy, experience of use and drug class. This grouping is intended to guide the design of individualized, longer M/XDR-TB regimens (the composition of the recommended shorter MDR/RR-TB regimen is largely standardized).
Resources
- Guidelines for Programmatic Management of Tuberculosis in India, 2021.
- WHO Consolidated Guidelines on Tuberculosis, Module 4 - Treatment: Drug-resistant TB Treatment, 2020.
Kindly provide your valuable feedback on the page to the link provided HERE
LMS Page Link
Content Creator
Reviewer
Target Audience
- Log in to post comments